SCHEMBL5315420

SCHEMBL5315420

CCOC(=O)C1CC(Oc2ccc(-n3ccnc3)cc2)CCN1c1ncccc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
MMP1 P03956 5/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CTSB P07858 1/20 0.39
GPR119 Q8TDV5 3/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 6/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 1/20 0.36
MITF O75030 1/20 0.36
NPC1 O15118 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5070681 0.86 CTSB (0.44) SMN1; SMN2MMP1CYP1A2CYP2D6CYP2C9
SCHEMBL6229171 0.71 MAPT (0.50) SMN1; SMN2CYP2C19CTSBGPR119KMT2A
SCHEMBL390386 0.70 GPR119 (0.51) CYP1A2CYP2D6CYP2C9CYP2C19CTSB
SCHEMBL6226161 0.70 CTSB (0.47) SMN1; SMN2CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL4706918 0.70 CYP1A2 (0.41) SMN1; SMN2MMP1CYP1A2CYP2D6CYP2C9
SCHEMBL389332 0.69 GPR119 (0.59) CYP1A2CYP2D6CYP2C9CYP2C19CTSB
SCHEMBL5267022 0.68 GPR119 (0.47) SMN1; SMN2MMP1CYP1A2CYP2D6CYP2C9
SCHEMBL31343761 0.68 SMN1; SMN2 (0.59) SMN1; SMN2CYP1A2CYP2C9CYP2C19CTSB
SCHEMBL4255322 0.68 CTSB (0.68) CYP1A2CYP2C9CYP2C19CTSBGPR119
SCHEMBL14633752 0.68 MAPT (0.43) SMN1; SMN2MMP1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599468-B1 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO SUCH AS DIABETES AND HYPERGLYCEMIA ARENA PHARM INC (US) 2007-10-03 EP disclosed